Your session is about to expire
← Back to Search
Early Catheter Removal After Colorectal Surgery
N/A
Recruiting
Research Sponsored by University of Southern California
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
American Society of Anesthesiologists (ASA) class I-III
Elective procedures involving total mesorectal excision, including low anterior resection and abdominoperineal resection for rectal cancer as well as proctectomy for inflammatory bowel disease
Must not have
History of urinary retention after previous procedure, surgery, or urinary catheter removal
Patients requiring prolonged duration or replacement of urinary catheter in the postoperative period for reasons other than urinary retention
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing if removing the urinary catheter shortly after colorectal surgery is as safe as removing it later. It targets patients who have had TME surgery to see if early removal can prevent urine buildup without increasing complications. The goal is to reduce infections and shorten hospital stays.
Who is the study for?
Adults over 18 undergoing elective colorectal surgery for rectal cancer or inflammatory bowel disease, who can sign consent. It's open to all surgical approaches and includes those with prior chemo/radiation treatments. Excludes emergency surgeries, combined major procedures, previous urinary issues like retention or injuries during surgery.
What is being tested?
The study is testing if removing the urinary catheter on day 1 after colorectal surgery is as safe as the standard practice of removal on day 3. The goal is to see if early removal reduces urinary infections and hospital stays without increasing the risk of urine retention.
What are the potential side effects?
Potential side effects include an increased risk of postoperative urinary retention when the catheter is removed earlier than usual, and possible urinary tract infections associated with prolonged catheter use.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My health is good to moderate, as rated by an anesthesiologist.
Select...
I am scheduled for or have had surgery for rectal cancer or inflammatory bowel disease.
Select...
I am 18 years old or older.
Select...
I have had chemotherapy or radiation before surgery.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have had trouble urinating after a past surgery or catheter removal.
Select...
I need a long-term urinary catheter after surgery for reasons other than not being able to urinate.
Select...
I am having surgery soon due to an emergency.
Select...
I have had surgery to remove my bladder or create a new urine passage.
Select...
I am having a major rectal surgery along with other big surgeries on the same day.
Select...
I have had issues with not being able to empty my bladder fully but am not currently receiving treatment for it.
Select...
I am under 18 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Urinary catheter removal on postoperative day 1Experimental Treatment1 Intervention
Group II: Urinary catheter removal on postoperative day 3Active Control1 Intervention
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
In colorectal surgery, urinary catheterization is used to prevent urinary retention by draining urine from the bladder. However, prolonged catheterization can increase the risk of urinary tract infections (UTIs).
The timing of catheter removal is critical to balance these risks. Shorter catheterization durations (e.g., 1 day) aim to reduce infection risk while still preventing retention, whereas standard durations (e.g., 3 days) may be used to ensure complete bladder emptying.
This balance is essential for optimizing postoperative recovery and minimizing complications in colorectal surgery patients.
Find a Location
Who is running the clinical trial?
University of Southern CaliforniaLead Sponsor
946 Previous Clinical Trials
1,604,647 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had trouble urinating after a past surgery or catheter removal.I need a long-term urinary catheter after surgery for reasons other than not being able to urinate.My health is good to moderate, as rated by an anesthesiologist.I am having surgery soon due to an emergency.I have had surgery to remove my bladder or create a new urine passage.I am having a major rectal surgery along with other big surgeries on the same day.I am scheduled for or have had surgery for rectal cancer or inflammatory bowel disease.My surgery can be performed using any method without affecting the technique.I am 18 years old or older.I have had issues with not being able to empty my bladder fully but am not currently receiving treatment for it.I am under 18 years old.I have had chemotherapy or radiation before surgery.
Research Study Groups:
This trial has the following groups:- Group 1: Urinary catheter removal on postoperative day 3
- Group 2: Urinary catheter removal on postoperative day 1
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.